A TECHNICAL COMPARISON BETWEEN IGH AND BCL1/IGH MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE ANALYSIS IN MANTLE CELL LYMPHOMA

被引：0
|
作者：
Ghione, P. [1 ]
Monitillo, L. [1 ]
Barbero, D. [1 ]
Verardo, G. [1 ]
Drandi, D. [1 ]
Grimaldi, D. [1 ]
Genuardi, E. [1 ]
Mantoan, B. [1 ]
Cavallo, F. [1 ]
Vasta, M. [1 ]
Zaja, F. [2 ]
Visco, C. [3 ]
Cortelazzo, S. [4 ]
Boccadoro, M. [1 ]
Ladetto, M. [5 ]
Ferrero, S. [1 ]
机构：
[1] Univ Torino, Div Hematol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy
[2] AOUD SM Misericordia, Hematol, DISM, Piazzale Santa Maria della Misericordia, Udine, Italy
[3] S Bortolo Hosp, Dept Hematol, Vicenza, Italy
[4] Clin Humanitas Gavazzeni, Unita Oncol, Bergamo, Italy
[5] Azienda Osped SS Antonio & Biagio & Cesare Arrigo, Alessandria, Italy
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C057
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [41] Comparison of fluorescent consensus IgH PCR and allele specific oligoprobing in the detection of minimal residual disease (MRD) in childhood ALL.
    Owen, R
    Goulden, N
    Langlands, K
    Shiach, C
    Garland, R
    Knechtli, C
    Hancock, J
    Steward, C
    Potter, M
    Morgan, G
    Oakhill, A
    BLOOD, 1995, 86 (10) : 2939 - 2939
  • [42] A Case of Hairy Cell Leukemia With CCND1-IGH@ Translocation: Indolent Non-nodal Mantle Cell Lymphoma Revisited
    Chen, Dong
    Ketterling, Rhett P.
    Hanson, Curtis A.
    Colgan, Joseph P.
    Zent, Clive S.
    Viswanatha, David S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (07) : 1080 - 1084
  • [43] Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?
    Ferrero, Simone
    Dreyling, Martin
    HAEMATOLOGICA, 2017, 102 (07) : 1133 - 1136
  • [44] Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies
    Peterson, Jess F.
    Baughn, Linda B.
    Ketterling, Rhett P.
    Pitel, Beth A.
    Smoley, Stephanie A.
    Vasmatzis, George
    Smadbeck, James B.
    Greipp, Patricia T.
    Mangaonkar, Abhishek A.
    Thompson, Carrie A.
    Parikh, Sameer A.
    Chen, Dong
    Viswanatha, David S.
    BLOOD ADVANCES, 2019, 3 (08) : 1298 - 1302
  • [45] Blastoid Variant Mantle Cell Lymphoma with Amplified IGH/CCND1 Fusion: A Unique Case and Current Literature Review
    Goktas, Emine
    Sanal, Sumeyye
    Esen, Haci Hasan
    Tekinalp, Atakan
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2024, 62 (02): : 124 - 127
  • [46] CD5-negative Blastoid Variant Mantle Cell Lymphoma with Complex CCND1/IGH and MYC Aberrations
    Seok, Yoonmi
    Kim, Juwon
    Choi, Jong Rak
    Kim, Yu Ri
    Park, Seo-Jin
    Kim, Sue Jung
    Song, Jaewoo
    Lee, Kyung-A
    ANNALS OF LABORATORY MEDICINE, 2012, 32 (01) : 95 - 98
  • [47] Association of minimal residual disease levels with clinical outcomes in patients with mantle cell lymphoma: A meta-analysis
    Wu, Xue
    Lu, Hongyu
    Pang, Tao
    Li, Xue
    Luo, Hongzhi
    Tan, Hong
    Liu, Shan
    LEUKEMIA RESEARCH, 2021, 108
  • [48] Minimal Residual Disease and Survival Outcomes in Patients with Mantle Cell Lymphoma: a systematic review and meta-analysis
    Zhou, Yu
    Chen, Haizhu
    Tao, Yunxia
    Zhong, Qiaofeng
    Shi, Yuankai
    JOURNAL OF CANCER, 2021, 12 (02): : 553 - 561
  • [49] Detection of IgH/MYC rearrangement in childhood Burkitt's lymphomas and B-cell ALL for the analysis of minimal residual disease by combined PCR methods
    Busch, K
    Borkhardt, A
    Harbott, J
    Reiter, A
    LEUKEMIA, 2001, 15 (12) : 2019 - 2019
  • [50] Non-MTC IGH-CCND1 Breakpoints in Mantle Cell Lymphoma Are Associated with CpG Sites and AID Hotspots
    Greisman, Harvey A.
    Lu, Zhengfei
    Tsai, Albert G.
    Greiner, Timothy C.
    Yi, Hye Son
    Lieber, Michael R.
    BLOOD, 2011, 118 (21) : 183 - 183
12345